Pneumonology in the COVID-19 pandemic Terapia 2021, 1 ( 396 ) : 32 - 36
Breezhaler®: Dry powder capsule inhaler
Summary:
Current knowledge on the Breezhaler® dry powder capsule in-haler is presented. The Breezhaler® inhaler minimizes the effort that the patient has to make to perform the correct inhalation maneuver. It is a flow-independent inhaler in the optimal range of inspiratory flow at the level of 50-100 L/min. and easy to use for the first time. It is also dedicated to patients with severe forms of COPD. All classes of inhalers for your long-term asthma or COPD treatment are available in the Breezhaler® inhaler.
Keywords: dry powder inhalers, capsule inhalers, Breezhaler®, carbon footprint, asthma, chronic obstructive pulmonary disease
If you would like to get the full article in Polish please contact our editorial office via email.
Add new comment